Medical Devices

NeoGenomics is raising $275M via convertible notes. We dissect the sophisticated financing, from dilution-hedging calls to the market impact for investors.

Adaptive Biotechnologies plans to separate its profitable diagnostics arm from its high-potential discovery engine. A deep dive into the financial calculus.

Adaptive Biotechnologies' new debt offering is more than a financial tune-up; it's a calculated move to sever a costly royalty deal and arm its star MRD division for a separate future.

e.l.f. Beauty, a titan of viral cosmetics, is entering the haircare chat. This is more than a new product; it's a test of its disruptive model.

As Mount Pleasant Group marks its 200th anniversary, it's deploying goats and bees to manage historic grounds, transforming spaces of remembrance into vibrant ecosystems.

A record $10M gift establishes a new research chair, honoring a titan of Canadian finance and positioning Montreal to solve the critical organ shortage.

Kimberly-Clark's new campaign with Deion Sanders is more than a celebrity deal; it's a strategic masterclass in using raw authenticity to disrupt a silent market.

A small-town medical spa is investing in cutting-edge tech for body, bladder, and brain. Is this the future of healthcare or a high-stakes gamble?

New clinical trial results for XWRAP® show a significant leap in healing diabetic ulcers, positioning Applied Biologics as a formidable player in a challenging field.

Replacing your home's siding is more than a cosmetic upgrade. Experts warn that skipping a crucial inspection can lead to costly structural damage and energy loss.

BVI's new European training hub isn't just a facility; it's a response to a critical skills gap in medicine, revealing how industry is shaping our trust in healthcare.

QTREX Quantum's electronics 3D printing tech achieved 97% yield at a top US manufacturer, moving to the production floor. A quantum leap for electronics.

Beyond the trade show floor, Chenwei Medical is executing a calculated strategy to fuse advanced critical care tech with deep clinical expertise in Latin America.

A new partnership between AI consultancy Toboggan Labs and research giant Mila aims to solve a critical problem: turning cutting-edge AI into real-world medical tools.

Lexeo Therapeutics finalizes a pivotal trial for its Friedreich ataxia gene therapy, leveraging a novel trial design and accelerated FDA pathway.

Ricola bets big, moving beyond the medicine cabinet with new functional drops. Can the heritage brand reinvent itself for the modern wellness consumer?

Johnson & Johnson's massive investment in Jacksonville promises economic growth, but the real story is a strategic pivot to secure the U.S. healthcare supply chain.

Apollo Art Auctions' latest sale, featuring a mysterious 'Prince Collection,' puts the spotlight on the modern antiquities market's high-stakes game of trust.

Aussie biotech ENA Respiratory secures crucial US patents for its novel immune modulator, signaling a major strategic move in the multi-billion dollar fight against COPD.

As Southeast Asia races to become an EV powerhouse, the real challenge lies on the factory floor. A new wave of traceable assembly tech aims to solve it.